MX2010002316A - Derivados tetraciclicos de indol y su uso para el tratamiento o prevencion de infecciones virales. - Google Patents
Derivados tetraciclicos de indol y su uso para el tratamiento o prevencion de infecciones virales.Info
- Publication number
- MX2010002316A MX2010002316A MX2010002316A MX2010002316A MX2010002316A MX 2010002316 A MX2010002316 A MX 2010002316A MX 2010002316 A MX2010002316 A MX 2010002316A MX 2010002316 A MX2010002316 A MX 2010002316A MX 2010002316 A MX2010002316 A MX 2010002316A
- Authority
- MX
- Mexico
- Prior art keywords
- treating
- indole derivatives
- tetracyclic indole
- viral infections
- preventing viral
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96868407P | 2007-08-29 | 2007-08-29 | |
PCT/US2008/010147 WO2009032123A2 (en) | 2007-08-29 | 2008-08-27 | Tetracyclic indole derivatives and their use for treating or preventing viral infections |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010002316A true MX2010002316A (es) | 2010-03-22 |
Family
ID=40319417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010002316A MX2010002316A (es) | 2007-08-29 | 2008-08-27 | Derivados tetraciclicos de indol y su uso para el tratamiento o prevencion de infecciones virales. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP2197884A2 (ko) |
JP (1) | JP5179585B2 (ko) |
KR (1) | KR20100061819A (ko) |
CN (1) | CN101842376A (ko) |
AR (1) | AR068109A1 (ko) |
AU (1) | AU2008295483B2 (ko) |
CA (1) | CA2697451A1 (ko) |
MX (1) | MX2010002316A (ko) |
TW (1) | TW200918536A (ko) |
WO (1) | WO2009032123A2 (ko) |
ZA (1) | ZA201001391B (ko) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2523580T3 (es) | 2008-01-11 | 2014-11-27 | Albany Molecular Research, Inc. | Piridoindoles substituidos con (1-Azinona) |
US8901139B2 (en) * | 2008-06-13 | 2014-12-02 | Merck Sharp & Dohme Corp. | Tricyclic indole derivatives and methods of use thereof |
JP2011528686A (ja) | 2008-07-23 | 2011-11-24 | エフ.ホフマン−ラ ロシュ アーゲー | ヘテロ環式抗ウイルス性化合物 |
EP2334662A1 (en) | 2008-09-26 | 2011-06-22 | F. Hoffmann-La Roche AG | Pyrine or pyrazine derivatives for treating hcv |
CN102448936A (zh) | 2009-04-25 | 2012-05-09 | 弗·哈夫曼-拉罗切有限公司 | 杂环抗病毒化合物 |
EP2435424B1 (en) | 2009-05-29 | 2015-01-21 | Merck Sharp & Dohme Corp. | Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c |
AR077004A1 (es) | 2009-06-09 | 2011-07-27 | Hoffmann La Roche | Compuestos heterociclicos antivirales |
JP2012530751A (ja) | 2009-06-24 | 2012-12-06 | エフ.ホフマン−ラ ロシュ アーゲー | 複素環式の抗ウイルス性化合物 |
EP2448585B1 (en) | 2009-07-01 | 2014-01-01 | Albany Molecular Research, Inc. | Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof |
WO2011003021A1 (en) | 2009-07-01 | 2011-01-06 | Albany Molecular Research, Inc. | Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof |
WO2011003007A1 (en) | 2009-07-01 | 2011-01-06 | Albany Molecular Research, Inc. | Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof |
WO2011003012A1 (en) | 2009-07-01 | 2011-01-06 | Albany Molecular Research, Inc. | Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof |
EP2480533A1 (en) | 2009-09-21 | 2012-08-01 | F. Hoffmann-La Roche AG | Heterocyclic antiviral compounds |
WO2011066241A1 (en) | 2009-11-25 | 2011-06-03 | Schering Corporation | Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases |
CA2785488A1 (en) | 2009-12-22 | 2011-07-21 | Merck Sharp & Dohme Corp. | Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases |
PE20130062A1 (es) | 2010-03-09 | 2013-02-28 | Merck Sharp & Dohme | Compuestos de sililo triciclicos fusionados para el tratamiento de enfermedades virales |
CN102858547A (zh) | 2010-05-02 | 2013-01-02 | Xjet有限公司 | 带有自清洗、防沉积与除烟气装置的打印系统 |
WO2012018534A2 (en) | 2010-07-26 | 2012-02-09 | Schering Corporation | Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases |
WO2012041227A1 (en) * | 2010-09-29 | 2012-04-05 | Merck Sharp & Dohme Corp. | Tetracyclic heterocycle compounds for treating hepatitis c viral infection |
AU2011314168A1 (en) | 2010-09-29 | 2013-04-04 | Merck Sharp & Dohme Corp. | Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases |
WO2012088038A2 (en) | 2010-12-21 | 2012-06-28 | Albany Molecular Research, Inc. | Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof |
WO2012088124A2 (en) | 2010-12-21 | 2012-06-28 | Albany Molecular Research, Inc. | Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof |
PE20140522A1 (es) | 2011-04-13 | 2014-05-03 | Merck Sharp & Dohme | Derivados de nucleosidos 2'- sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales |
US9156872B2 (en) | 2011-04-13 | 2015-10-13 | Merck Sharp & Dohme Corp. | 2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases |
WO2013033899A1 (en) | 2011-09-08 | 2013-03-14 | Merck Sharp & Dohme Corp. | Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases |
WO2013033900A1 (en) | 2011-09-08 | 2013-03-14 | Merck Sharp & Dohme Corp. | Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases |
WO2013033901A1 (en) | 2011-09-08 | 2013-03-14 | Merck Sharp & Dohme Corp. | Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases |
WO2013039876A1 (en) | 2011-09-14 | 2013-03-21 | Merck Sharp & Dohme Corp. | Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases |
US9457039B2 (en) | 2012-10-17 | 2016-10-04 | Merck Sharp & Dohme Corp. | 2′-disubstituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases |
AR092959A1 (es) | 2012-10-17 | 2015-05-06 | Merck Sharp & Dohme | Derivados de nucleosidos 2-metil sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales |
US9242988B2 (en) | 2012-10-17 | 2016-01-26 | Merck Sharp & Dohme Corp. | 2′-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases |
RU2015123641A (ru) | 2012-11-19 | 2017-01-10 | Мерк Шарп И Доум Корп. | 2-алкинилзамещенные производные нуклеозидов, предназначенные для лечения вирусных заболеваний |
US9765107B2 (en) | 2013-06-18 | 2017-09-19 | Merck Sharp & Dohme Corp. | Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases |
WO2014205593A1 (en) | 2013-06-24 | 2014-12-31 | Merck Sharp & Dohme Corp. | Substituted benzofuran compounds and methods of use thereof for treatment of viral diseases |
WO2014205592A1 (en) | 2013-06-24 | 2014-12-31 | Merck Sharp & Dohme Corp. | Heterocyclic compounds and methods of use thereof for treatment of hepatitis c |
WO2015065817A1 (en) | 2013-10-30 | 2015-05-07 | Merck Sharp & Dohme Corp. | Pseudopolymorphs of an hcv ns5a inhibitor and uses thereof |
WO2017223012A1 (en) | 2016-06-20 | 2017-12-28 | Merck Sharp & Dohme Corp. | Cyclic phosphate substituted nucleoside compounds and methods of use thereof for the treatment of viral diseases |
CN112898312B (zh) * | 2021-01-29 | 2021-11-12 | 湖南南新制药股份有限公司 | 一种稠合多环吡啶酮衍生物及其用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7153848B2 (en) * | 2004-08-09 | 2006-12-26 | Bristol-Myers Squibb Company | Inhibitors of HCV replication |
WO2006034337A2 (en) * | 2004-09-23 | 2006-03-30 | Wyeth | Carbazole and cyclopentaindole derivatives to treat infection with hepatitis c virus |
GB0518390D0 (en) * | 2005-09-09 | 2005-10-19 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
WO2007038209A2 (en) * | 2005-09-23 | 2007-04-05 | Schering Corporation | Fused tetracyclic mglur1 antagonists as therapeutic agents |
-
2008
- 2008-08-27 JP JP2010522933A patent/JP5179585B2/ja not_active Expired - Fee Related
- 2008-08-27 AR ARP080103718A patent/AR068109A1/es not_active Application Discontinuation
- 2008-08-27 EP EP08795628A patent/EP2197884A2/en not_active Withdrawn
- 2008-08-27 TW TW097132762A patent/TW200918536A/zh unknown
- 2008-08-27 CA CA2697451A patent/CA2697451A1/en not_active Abandoned
- 2008-08-27 MX MX2010002316A patent/MX2010002316A/es not_active Application Discontinuation
- 2008-08-27 KR KR1020107006704A patent/KR20100061819A/ko not_active Application Discontinuation
- 2008-08-27 AU AU2008295483A patent/AU2008295483B2/en not_active Ceased
- 2008-08-27 WO PCT/US2008/010147 patent/WO2009032123A2/en active Application Filing
- 2008-08-27 CN CN200880113543A patent/CN101842376A/zh active Pending
-
2010
- 2010-02-25 ZA ZA2010/01391A patent/ZA201001391B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2009032123A3 (en) | 2009-06-11 |
KR20100061819A (ko) | 2010-06-09 |
TW200918536A (en) | 2009-05-01 |
EP2197884A2 (en) | 2010-06-23 |
JP2010537980A (ja) | 2010-12-09 |
ZA201001391B (en) | 2010-11-24 |
CA2697451A1 (en) | 2009-03-12 |
CN101842376A (zh) | 2010-09-22 |
AU2008295483A1 (en) | 2009-03-12 |
AR068109A1 (es) | 2009-11-04 |
AU2008295483B2 (en) | 2013-11-21 |
JP5179585B2 (ja) | 2013-04-10 |
WO2009032123A2 (en) | 2009-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010002316A (es) | Derivados tetraciclicos de indol y su uso para el tratamiento o prevencion de infecciones virales. | |
MX2010002317A (es) | Derivados de indol sustituidos y metodos para su utilizacion. | |
MX2010005356A (es) | Derivados de indol 3-heterociclico sustituidos y metodos de uso de los mismos. | |
MX2010002319A (es) | Derivados indolicos 2,3 sustituidos para el tratamiento de infecciones virales. | |
MX2010005355A (es) | Derivados de indol sustituidos con 3-aminosulfonilo y metodos de uso de los mismos. | |
MX2010002318A (es) | Derivados azaindol 2,3-sustituidos para tratar infecciones virales. | |
TW200833684A (en) | 5,6-ring annulated indole derivatives and methods of use thereof | |
TW200833662A (en) | 4,5-ring annulated indole derivatives and methods of use thereof | |
MX363189B (es) | Productos químicos, composiciones y métodos para tratamiento y prevención de infecciones de virus orthopox y enfermedades asociadas. | |
MX2012011222A (es) | Compuestos y composiciones farmaceuticas para el tratamiento de infecciones virales. | |
CL2012001176A1 (es) | Compuestos derivados de bencimidazol-imidazol, inhibidores del virus de la hepatitis c (hcv); composición farmacéutica que los comprende; combinación farmacéutica; uso en la prevención o tratamiento de infección de hcv. | |
MX2009009473A (es) | Compuestos para el tratamiento de hepatitis c. | |
TN2013000421A1 (en) | 2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases | |
MX2013003634A (es) | Derivados policiclicos heterociclicos y metodos de uso de los mismos para el tratamiento de enfermedades virales. | |
WO2008127364A3 (en) | Antiviral compounds and use thereof | |
UA100250C2 (uk) | Інгібітори реплікації вірусу імунодефіциту людини | |
ECSP099447A (es) | Derivados indólicos con anillo unido en las posiciones 4,5 y sus métodos de uso | |
MA33806B1 (fr) | Inhibiteurs du virus de l'hepatite c | |
NO20064547L (no) | Fremgangsmater for behandling av HIV infeksjon | |
WO2009149179A3 (en) | Enhanced antiviral therapy methods and devices | |
WO2008115281A3 (en) | Compounds for treating viral infections | |
EA021554B9 (ru) | Органические соединения и их применение для лечения hcv инфекции | |
MX2010006206A (es) | Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. | |
UA102858C2 (ru) | Производные пиридино-пиридинонов, способ их получения и применения в терапии | |
MX2008013196A (es) | 5-amido-2-carboxiamida-indoles. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HH | Correction or change in general | ||
FA | Abandonment or withdrawal |